166483
Saroglitazar
Size
£491.00
- SKU:
- 166483
- Molecular Weight:
- 439.57
- Purity:
- As reported
- Storage Conditions:
- 4°C
- Supplier:
- United States Biological
- CAS Number:
- 495399-09-2
- Format:
- Red gel
- Extra Details:
- Saroglitazar is a drug for the treatment of type 2 diabetes mellitus and dyslipidemia. It is approved for use in India by the Drug Controller General of India. Saroglitazar has demonstrated reduction of triglycerides (TG), LDL cholesterol, VLDL cholesterol, non-HDL cholesterol and an increase in HDL cholesterol a characteristic hallmark of atherogenic diabetic dyslipidemia (ADD). Saroglitazar is novel first in class drug which acts as a dual PPAR agonist at the subtypes α (alpha) and γ (gamma) of the peroxisome proliferator-activated receptor (PPAR). Agonist action at PPARα lowers high blood triglycerides, and agonist action on PPARγ improves insulin resistance and consequently lowers blood sugar. Synonyms: (αS)-α-Ethoxy-4-[2-[2-methyl-5-[4-(methylthio)phenyl]-1H-pyrrol-1-yl]ethoxy]benzenepropanoic Acid; ZYH1; ZYH-1; ZYH 1; Lipaglyn. IUPAC/Chemical Name: (S)-2-ethoxy-3-(4-(2-(2-methyl-5-(4-(methylthio)phenyl)-1H-pyrrol-1-yl)ethoxy)phenyl)propanoic acid CAS No: 495399-09-2 Molecular Formula: C₂₅H₂₉NO₄S Molecular Weight: 439.57 Appearance: Red gel Purity: As reported Solubility: Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly) Storage and Stability: Store at 4°C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
- Shipping Conditions:
- Ambient